{
    "2018-09-20": [
        [
            {
                "time": "",
                "original_text": "复星医药：集团今年将有五十余个品种开展一致性评价",
                "features": {
                    "keywords": [
                        "复星医药",
                        "一致性评价",
                        "药品"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【晨会聚焦】锂电中游再扬帆，医药价值渐显现",
                "features": {
                    "keywords": [
                        "锂电",
                        "医药",
                        "价值显现"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "锂电池"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "药明康德启动在港上市程序 或成第三只A+H医药股",
                "features": {
                    "keywords": [
                        "药明康德",
                        "A+H股",
                        "上市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "登陆沪市百余日再望香江 药明康德启动“A+H”计划",
                "features": {
                    "keywords": [
                        "药明康德",
                        "A+H计划",
                        "上市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}